Isthmus Partners LLC acquired a new position in Amdocs Limited (NASDAQ:DOX – Free Report) in the 3rd quarter, Holdings Channel.com reports. The institutional investor acquired 3,709 shares of the technology company’s stock, valued at approximately $324,000.
Several other large investors also recently bought and sold shares of the business. Private Trust Co. NA grew its stake in shares of Amdocs by 62.9% during the 3rd quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock valued at $27,000 after purchasing an additional 117 shares during the period. Brooklyn Investment Group bought a new stake in shares of Amdocs during the 3rd quarter valued at about $28,000. Catalyst Capital Advisors LLC bought a new stake in shares of Amdocs during the 3rd quarter valued at about $55,000. GAMMA Investing LLC grew its stake in shares of Amdocs by 115.1% during the 3rd quarter. GAMMA Investing LLC now owns 800 shares of the technology company’s stock valued at $70,000 after purchasing an additional 428 shares during the period. Finally, Meeder Asset Management Inc. bought a new stake in shares of Amdocs during the 3rd quarter valued at about $77,000. 92.02% of the stock is currently owned by institutional investors.
Amdocs Trading Down 0.5 %
Shares of NASDAQ:DOX opened at $86.72 on Friday. The stock has a 50 day moving average of $88.08 and a 200 day moving average of $84.07. The company has a market cap of $10.19 billion, a PE ratio of 20.45, a price-to-earnings-growth ratio of 1.46 and a beta of 0.74. The company has a current ratio of 1.20, a quick ratio of 1.24 and a debt-to-equity ratio of 0.21. Amdocs Limited has a 12-month low of $74.41 and a 12-month high of $94.04.
Amdocs Announces Dividend
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on the company. Barclays cut their price target on Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a research note on Thursday, November 14th. Stifel Nicolaus assumed coverage on Amdocs in a research note on Wednesday, October 2nd. They set a “buy” rating and a $100.00 price target for the company. StockNews.com downgraded Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 14th. Finally, Oppenheimer boosted their price objective on Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $101.83.
Get Our Latest Stock Analysis on DOX
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
- Five stocks we like better than Amdocs
- Stock Analyst Ratings and Canadian Analyst Ratings
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- What is a Special Dividend?
- 3 Penny Stocks Ready to Break Out in 2025
- Trading Halts Explained
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.